BMY
Bristol-Myers Squibb Co.
Updated: Oct 30, 2026, 2:17 AM
Open BMY on TradingViewAffiliate linkBristol-Myers Squibb Co.
Position vs 200-day MA
+2.5% above 200-day MA
BMY is 2.5% above its 200-day MA for 8 days and outranks most of Healthcare stocks, at the 67th percentile. That looks like genuine relative strength.
Price
$61.39
200-day MA
$59.92
Streak above
8 days
Avg volume (90d)
11.6M
Market cap
$123.7B
Participation around BMY
Above 200-day MABMY is above its 200-day average, but fewer Healthcare stocks are confirming the trend.
Healthcare
36%
310 of 855 stocks
S&P 500
63%
316 of 498 stocks
This stock is currently above its 200-day average. The comparison shows how much support the move has around it.
Trend timeline
Last 200-day cross
Moved above
Oct 20, 2026
Current state
Above the 200-day MA
8 trading days
Shorter averages
Mixed alignment
20, 50, and 200-day view
Technical peers
Closest 200-day positions in HealthcareCorrelation vs. Healthcare Peers
How BMY has moved with the 15 most liquid Healthcare stocks over the trailing 60 trading days.
Most Correlated
Most Inverse
Stocks most correlated with BMY
Ranked against every S&P 500 stock using daily returns over the last 60 trading days. A value near +1 means the two tend to move together and near -1 means they tend to move opposite; most pairs sit well below those extremes.
Most correlated with BMY
See the strongest pairs across the whole index on the S&P 500 correlation pairs page.